M. HGF ameliorates a high-fat diet-induced fatty liver.
FATTY LIVER IS A COMMON DISEASE in patients accompanied with obesity and diabetes, and one of the major causes to develop obesity and diabetes in humans is a high-fat diet.
Nonalcoholic fatty liver disease (NAFLD) has been increasing as a condition which eventually progresses to end-stage liver disease. The pathological picture resembles that of alcohol-induced liver injury, but it occurs in patients who do not abuse alcohol. NAFLD affects 10 -24% of the general population in various countries. The prevalence increases to 57.5-74% in obese populations (1) .
Although various ways of treating this disease have been advocated (7, 21) , no definite medications have been proven to directly improve NAFLD.
NAFLD is a liver injury in which the histopathological abnormalities mimic those of alcoholic steatohepatitis (19) . Hepatocyte growth factor (HGF) administration has recently been shown to improve alcoholic fatty liver (28, 29) , but the precise effect of HGF on NAFLD remains to be elucidated. We therefore investigated whether or not HGF administration could possibly be effective for improving NAFLD.
HGF is a polypeptide originally characterized as a highly potent hepatocyte mitogen (10, 20) . Recent studies have shown HGF to be a multifunctional cytokine that can elicit mitogenic, motogenic, and morphogenic responses in a variety of cultured epithelial cells expressing the transmembrane tyrosine kinase receptor, c-Met (5, 38) .
We have developed and maintained HGF transgenic line and disclosed several phenotypes (25, 30, 32) . Using this mouse model, we examined the effect of HGF in NAFLD with the high-fat diet. Moreover, subsequent studies led to the understanding that the improvement of alcoholic liver injury was followed by the upregulation of microsomal triglyceride transfer protein (MTP) and apolipoprotein B (ApoB) (28, 29) . We therefore performed a further examination as follows using the MTP and ApoB in the NAFLD model.
MTP is a rate-limiting factor for the production of ApoBcontaining very-low-density lipoproteins (12, 18, 37) . MTP is an exclusive intracellular protein (12) and its principal role is to transfer lipids onto the ApoB polypeptides in the endoplasmic reticulum of lipoprotein-secreting cells (12) .
We herein demonstrated that an overexpression of HGF dramatically ameliorated a high-fat diet-induced fatty liver in vivo. Furthermore, we showed this protective effect of HGF to be due to MTP and ApoB activation.
METHODS
Transgenic mice and treatment. Transgenic mice (Tg), in which the expression of a murine HGF cDNA was driven by the metallothionein promoter and locus control regions, were generated on the inbred albino FVB/NCr genetic background (hereafter referred to as FVB) as described previously (30) . Furthermore, Takayama et al. demonstrated that HGF transgene expressed in all organs and there were a number of phenotypes, such as hepatomegaly, cystic disease accompanied by focal segmental glomerulosclerosis, ulceration associated with chronic active inflammation of the rectum, and so on (25, (31) (32) (33) .
Six-to 8-wk-old male Tg and FVB wild-type mice (WT) were used. All animal studies were performed according to the guidelines for animal care and use established by Institutional Review Board of Gunma University Graduate School of Medicine. WT and Tg were placed after weaning (3 wk of age) on either a high-fat diet (60% of calories derived from fat; D12492, Research Diets, New Brunswick, NJ) or a normal chow diet (10% of calories derived from fat; D12450B, Research Diets). The mice were pair-fed on these diets for 4 wk.
Biochemical and histological analysis. Lipids were extracted from 50 mg of liver homogenate, and the lipid concentration per wet liver weight was measured according to the method described previously (9) . For the histological analysis, liver tissue was fixed in 4% paraformaldehyde and embedded in paraffin. Alternatively, the hepatic lipids were stained by an Oil Red O method. For the protein or RNA analysis, tissue specimens were frozen in liquid nitrogen and stored at Ϫ80°C until used. Serum concentrations of alanine aminotransferase (ALT), triglyceride, and serum glucose were measured with a standard clinical autoanalyzer (Hitachi 7170; Hitachi, Tokyo, Japan). The serum insulin level was determined using an insulin radioimmunoassay kit (Shionogi, Osaka, Japan) according to the manufacturer's instructions. The serum glucose and insulin level were measured by using the samples extracted after 12 h of fasting.
ApoB in the serum or medium were determined using the ApoB ELISA kit (ALerCHEK, Portland, ME) according to the manufacturer's instructions.
RNA analysis. The human hepatocarcinoma cell, HepG2, was obtained from the American Type Culture Collection (Manassas, VA). HepG2 cells (2 ϫ 10 5 ) were seeded in a 35-mm dish for 24 h, the medium was exchanged with serum-free DMEM (GIBCO BRL, Grand Island, NY), and the cells were then incubated overnight. Furthermore, these cells were incubated for 6 h with 40 ng/ml of the recombinant human HGF (rhHGF; R&D Systems, Minneapolis, MN), with or without 20 M of a MAPK inhibitor, PD98059 (SigmaAldrich Japan K.K., Tokyo, Japan), or a phosphatidylinositol 3 kinase (PI3K) inhibitor, wortmannin (Sigma-Aldrich Japan K.K.), for 1 h before HGF stimulation. RNA collection, RT-PCR, and real-time PCR methods using mice liver tissue or cells were described previously (17) . The sequence details are shown in Table 1 .
Microarray experiments. The quality of total RNA from the mouse liver tissue specimens as evaluated by A 260/A280 ratio, which was at least 1.9, and by gel electrophoresis pattern, which revealed two major bands of 28S and 18S RNA. The sample labeling, microarray hybridization, washing, and scanning were performed according to the manufacturer's protocols (Affymetrix, Santa Clara, CA). Labeled cRNA was prepared and subsequently hybridized to Affymetrix MOE430A array (containing 22,690 transcripts, almost 14,500 known genes, and 4,371 expressed sequence tags). The arrays were then scanned with the GeneArray Scanner (GeneArray 2500 scanner, Affymetrix). The data obtained through GeneChip scanning was analyzed with Affymetrix Microarray Suit Software 5.0 (Affymetrix). Before the two arrays were compared, the GeneChip software program was used to normalize and scale the data for each array. The mRNA expression level of a transcript is directly related to the signal, which is a quantitative metric calculated for each probe set and measures the mean difference of the fluorescence intensity between the perfect match and the central mismatch oligonucleotides of a probe set. Change measures the probability that the expression levels of a probe set in two different arrays are the same or not. The magnitude and direction of change of a transcript were indicated as the fold change.
Hepatic MTP activity. The hepatic MTP activity was determined by using a commercial kit based on the MTP-mediated transfer of a self-quenched fluorescent neutral lipid from the core of a donor particle to an acceptor particle (Roar Biomedical, New York, NY).
Analysis of ApoB protein. For immunoprecipitation, 1,000 g of liver tissue lysate were incubated with anti-ApoB antibody (Santa Cruz Biotechnology, Santa Cruz, CA) for 2 h on ice. After the addition of Gamma-Bind G Sepharose (Boehringer Mannheim, Mannheim, Germany) and washing in RIPA buffer, the immunoprecipitates were fractionated on 10% polyacrylamide gels (BIOCRAFT, Tokyo, Japan). A Western blot analysis was performed as described previously (17) .
Determination of the intracellular lipid content. HepG2 cells were incubated in complete medium with 10% fetal bovine serum in 100-mm-diameter dishes, grown to 70% confluence, and maintained in serum-free DMEM overnight. The cells were treated by in serumfree medium for 24 h, followed by incubation with or without 50 ng/ml rhHGF in medium for 24 h. Triglyceride contents were determined in cell lysates by a colorimetric assay and were expressed as milligrams of lipid per milligram of cellular protein as described previously (36) . The cell lysates were homogenized and transferred the supernatant and then mixed with chloroform-methanol and vortexed. After centrifugation, the lower layer was transferred and evaporated. We measured the triglyceride content after adding 2-propanol (Wako Chemical, Osaka, Japan).
Statistical analysis. All data were expressed as means Ϯ SD. The statistical analysis was performed by unpaired Student t-test or by one-way ANOVA. When the ANOVA analyses were applied, differences in the mean values among the groups were examined by Fisher's multiple comparison test.
RESULTS

Body weight, glucose metabolism, and serum ALT level.
Although the body weights of both WT and Tg were not different, relative liver weight per body weight of Tg was significantly higher than that of WT on the normal diet ( Table 2 ). The feed intake was not different between both the diet and mouse groups. Because it is said that abnormalities in insulin action may be involved in the pathogenesis of NAFLD, we measured the serum glucose and insulin concentration. As a result, these data between both mouse groups were not significantly different (Table 2) . Moreover, the high-fat diet did not affect the serum ALT levels in both mice (Fig. 1A) . Serum and hepatic triglyceride concentrations. The serum triglyceride of Tg was significantly higher than that of WT (37.2 Ϯ 26.1 vs. 256.9 Ϯ 191.2 mg/dl, *P Ͻ 0.05, Fig. 1B) . On the other hand, the triglyceride concentration in the WT liver increased more than that of the Tg liver (61.2 Ϯ 22.5 vs. 8.0 Ϯ 7.5 mg/g wet liver, P Ͻ 0.01, Fig. 1C ).
Furthermore, the phenotype induced by hyperlipidemia such as the fat embolism, arteriosclerosis, or pancreatitis, etc. was not observed. Moreover, no systemic inflammatory reactions including inflammation in the liver were observed either.
Histological analysis of the liver. On the normal diet, the histological findings did not differ substantially between the WT and Tg liver (Fig. 1D, a and b) . However, on the high-fat diet, lipid droplets accumulated in the hepatocytes in both the perivenular and the periportal area in WT. On the other hand, in Tg, lipid droplets were localized only around the perivenular area (Fig. 1D, c-f ) .
Gene expression relating to oxidation and triglyceride synthesis. To elucidate the difference of gene expression between WT and Tg, we applied DNA microarrays to reveal differential mRNA expression between both mice livers. The gene expressions in the liver related to oxidation such as acyl-CoA oxidase, carnitine acetyltransferase, uncoupling protein 2, and (Table 3) . These DNA microarrays results were confirmed by real-time PCR analysis (primers are shown in Table 2 ; data not shown).
On the other hand, the transcriptome analysis in Tg liver allowed us to reveal upregulation of MTP and ApoB. HGF administration has recently been shown to improve alcoholic fatty liver by the upregulation of MTP and ApoB (28, 29) . Therefore, we performed a further examination as follows for MTP and ApoB.
Hepatic MTP gene expression and activity. The MTP expression ( Fig. 2A) and MTP activity (Fig. 2B ) in Tg were higher than those in WT on the normal and high-fat diet. Furthermore, the high-fat diet significantly increased MTP expression and MTP activity in both mice.
Hepatic ApoB gene expression and ApoB protein content. In Tg, the ApoB expression was significantly higher than that in WT (Fig. 2C) . However, a high-fat diet did not accelerate the ApoB expression. In a similar way, Western blotting showed that the level of ApoB protein in the liver increased in Tg and high-fat diet did not increase the ApoB protein level in either of the groups.
A Western blotting analysis showed that ApoB protein increased in the Tg liver (Fig. 2D) . The serum ApoB concentration of Tg was significantly higher than that of WT on the normal and high-fat diet (Fig. 2E) .
MTP expression and activity and ApoB expression and secretion induced by rhHGF in HepG2 cell line. The MTP expression (Fig. 3A) and activity (Fig. 3B ) and the ApoB expression (Fig. 3C) and secretion (Fig. 3D) both significantly increased by rhHGF stimulation. All these effects were significantly inhibited by the coadministration of rhHGF and PD98059, whereas only PD98059 administration had no effect on these parameters (Fig. 3, A-D) . On the other hand, the wortmannin treatment did not block any HGF effect (data not shown).
Intracellular triglyceride contents. The addition of rhHGF into the media induced a reduction of the intracellular lipid content (Fig. 3E) . Furthermore, the pretreatment of PD95059, an MAPK inhibitor, blocked this rhHGF effect. These results indicated that HGF accelerates the lipid secretion to outside cell, and this effect seemed to act through the MAPK pathway, at least in part.
DISCUSSION
In the present study, we clearly demonstrated that an overexpression of HGF dramatically ameliorates a high-fat diet-induced fatty liver in vivo, as well as the mechanism of the acceleration of lipid secretion from the liver by HGF. In in vitro studies, HGF had been reported to regulate the lipid metabolism, such as the stimulation of lipid synthesis and lipoprotein secretion (15, 16, 24, 26, 27) . On the other hand, in in vivo studies, the antidiabetic reagents pioglitazone and metformin were reported to improve alcoholic fatty liver by inducing the ApoB expression and MTP activity through c-met activation (3, 34) . Moreover, Borowiak et al. (4) reported that the long-term loss of Met does lead to microvesicular steatosis in the conditional Met mutation mice liver. We also demonstrated that in NK2 transgenic mice, a massive intracellular accumulation of lipid was observed in hepatocytes at 48 h after a partial hepatectomy (22) . As NK2 was thought to an HGF antagonist of a variety of biological activities (23), these two mouse models suggest that the HGF-c-Met signaling plays a crucial role in the lipid accumulation in the liver.
The hepatic triglyceride content is modulated by several factors affecting liver fatty acid synthesis and oxidation and triglyceride secretion from the liver (11) . The gene expression profiles regulating oxidation, triglyceride synthesis, or secretion are shown in Table 3 . There were no differences in these genes except for MTP and ApoB between WT and Tg. Furthermore, we also confirmed the expression levels of the representative genes by real-time PCR (Table 1) . As a result, among the many genes regulating triglyceride oxidation, synthesis, or secretion, the gene expression of ApoB and MTP was different between WT and Tg. Furthermore, we examined these genes more closely on the RNA, protein, and activity level as previously reported (28, 29) .
It has already been shown that an inhibitory effect on hepatic very-low-density lipoprotein secretion was one of the major causes of alcoholic fatty liver (6, 13, 35) . A previous study showed alcoholic fatty liver to be accompanied by MTP reduction, and HGF improved fatty liver through the normalization of the MTP expression (28, 29) . In our system, the MTP expression was increased more on the high-fat diet than on the normal diet ( Fig. 2A) . Therefore, HGF improved fatty liver regardless of the MTP expression level. Furthermore, we showed not only analyzed the protein levels related to the lipid secretion, but also that the intracellular lipid content decreased owing to HGF. However, further study would be needed to clarify the overview of HGF and the lipid metabolism.
On the other hand, the high-fat diet increased MTP mRNA but not ApoB mRNA. Because ApoB is posttranslationally controlled in their metabolic process (2, 8) , a high-fat diet could not accelerate ApoB expression (Fig. 2C) . However, ApoB expression in Tg was higher than that in WT. These data indicated that HGF directly affected ApoB in the transcriptional level in the different manner due to high-fat diet.
Because Ras/MAPK and PI3K cascades are thought to be the two major pathways in the HGF/c-Met signaling (39), we Fig. 2 . A: microsomal triglyceride transfer protein (MTP) mRNA expression in the liver on the normal-fat diet or high-fat diet. *P Ͻ 0.01 (n ϭ 3) B: MTP activity in the liver on the normal and high-fat diets; *P Ͻ 0.01 (n ϭ 3). C: apolipoprotein B (ApoB) mRNA expression in the liver on the normal and high-fat diets; *P Ͻ 0.01 (n ϭ 3). D: ApoB protein expression in the liver on the normal and high-fat diet. E: serum ApoB content on the normal and high-fat diet. WT, white bars; Tg, black bars. *P Ͻ 0.01 (n ϭ 6); ns., notsignificant.
investigated the signaling using MAPK inhibitor PD98059 and PI3K inhibitor wortmannin in vitro. The activation of MTP and ApoB by HGF was blocked by PD98059 not but wortmannin (Fig. 3) . This result indicated that the HGF/c-Met signaling regulated the MTP and ApoB expression through the MAPK pathway at least in part.
On the other hand, Tg has been reported to have several phenotypes, such as developmental anomalies (30) , renal dysfunction (31) , and intestinal disease (33) as well as hepatomegaly with spontaneous neoplastic transformation (25, 32) . When using HGF for the treatment of fatty liver in the future, it is necessary to pay close attention to such pathological changes including hepatocarcinogenesis.
In conclusion, HGF was found to ameliorate a high-fat diet-induced fatty liver while also inducing hyperlipidemia through the acceleration of the lipid secretion system including MTP and ApoB. HGF may therefore be a potentially effective treatment for NAFLD; however, further studies are needed to elucidate whether hyperlipidemia or oncogenesis (14) might be possible side effects of HGF administration. 
